By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RXi Pharmaceuticals 

1500 West Park Drive
Suite 210
Westborough  Massachusetts  01581  U.S.A.
Phone: 508-767-3861 Fax: 508-767-3862


Company News
RXi Pharma (RXII) Reports Fourth Quarter And Year End 2016 Financial Results And Recent Corporate Highlights 3/30/2017 9:39:34 AM
RXi Pharma (RXII) Granted Patent In Japan For Lead Clinical Candidate RXI-109 3/28/2017 7:50:45 AM
RXi Pharma (RXII) To Webcast Fourth Quarter And Year End 2016 Financial Results On Thursday, March 30, 2017 3/16/2017 11:27:26 AM
RXi Pharma (RXII) Appoints Medical Oncology Expert, Dr. James Griffin, To Scientific Advisory Board 2/14/2017 10:05:37 AM
RXi Pharma (RXII) Appoints Leading Oncology Expert, Dr. Rolf Kiessling, To Scientific Advisory Board 2/7/2017 8:30:43 AM
RXi Pharma (RXII) Completes Acquisition Of MirImmune Inc. And Appoints New Chief Business Officer 1/9/2017 7:43:45 AM
RXi Pharma (RXII) Announces Closing Of $11.5 Million Underwritten Public Offering And Full Exercise Of Over-Allotment Option 12/21/2016 12:16:08 PM
RXi Pharma (RXII) Announces Pricing Of $10 Million Underwritten Public Offering 12/16/2016 7:22:45 AM
RXi Pharma (RXII) Provides Year End Update On Its Business Development And Clinical Programs 12/13/2016 8:12:07 AM
RXi Pharma (RXII) Reports Third Quarter 2016 Financial Results And Highlights Recent Corporate Developments 11/11/2016 1:52:55 PM